Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Ivabradine 7.5 mg Tablets Under Fed Conditions in Healthy Thai Volunteers
TCTR20220908005Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ivabradine (2 arms), sponsored by International Bio Service. Planned start Jan 2023; status: not yet recruiting.
02
Drugs
ivabradine
Beyond the preview
Go deeper on TCTR20220908005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220908005.